Literature DB >> 12663672

Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes.

Eefjan Breukink1, Hester E van Heusden, Pauline J Vollmerhaus, Ewa Swiezewska, Livia Brunner, Suzanne Walker, Albert J R Heck, Ben de Kruijff.   

Abstract

The peptidoglycan layers surrounding bacterial membranes are essential for bacterial cell survival and provide an important target for antibiotics. Many antibiotics have mechanisms of action that involve binding to Lipid II, the prenyl chain-linked donor of the peptidoglycan building blocks. One of these antibiotics, the pore-forming peptide nisin uses Lipid II as a receptor molecule to increase its antimicrobial efficacy dramatically. Nisin is the first example of a targeted membrane-permeabilizing peptide antibiotic. However, it was not known whether Lipid II functions only as a receptor to recruit nisin to bacterial membranes, thus increasing its specificity for bacterial cells, or whether it also plays a role in pore formation. We have developed a new method to produce large amounts of Lipid II and variants thereof so that we can address the role of the lipid-linked disaccharide in the activity of nisin. We show here that Lipid II is not only the receptor for nisin but an intrinsic component of the pore formed by nisin, and we present a new model for the pore complex that includes Lipid II.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663672     DOI: 10.1074/jbc.M301463200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.

Authors:  Imke Wiedemann; Roland Benz; Hans-Georg Sahl
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

2.  Plasticity of Escherichia coli cell wall metabolism promotes fitness and antibiotic resistance across environmental conditions.

Authors:  Elizabeth A Mueller; Alexander Jf Egan; Eefjan Breukink; Waldemar Vollmer; Petra Anne Levin
Journal:  Elife       Date:  2019-04-09       Impact factor: 8.140

3.  Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.

Authors:  Sheila M Morgan; Paula M O'connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Synthesis of heptaprenyl-lipid IV to analyze peptidoglycan glycosyltransferases.

Authors:  Yi Zhang; Eric J Fechter; Tsung-Shing Andrew Wang; Dianah Barrett; Suzanne Walker; Daniel E Kahne
Journal:  J Am Chem Soc       Date:  2007-02-27       Impact factor: 15.419

6.  Substrate recognition and specificity of the NisB protein, the lantibiotic dehydratase involved in nisin biosynthesis.

Authors:  Antonino Mavaro; André Abts; Patrick J Bakkes; Gert N Moll; Arnold J M Driessen; Sander H J Smits; Lutz Schmitt
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

7.  Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic.

Authors:  Judicaël Parisot; Sarah Carey; Eefjan Breukink; Weng C Chan; Arjan Narbad; Boyan Bonev
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

8.  Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2.

Authors:  Dianah Barrett; Catherine Leimkuhler; Lan Chen; Deborah Walker; Daniel Kahne; Suzanne Walker
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

9.  Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Karolina Skorupinska-Tudek; Ewa Swiezewska; Michio Kurosu
Journal:  Anal Biochem       Date:  2014-06-02       Impact factor: 3.365

10.  The First structure of a lantibiotic immunity protein, SpaI from Bacillus subtilis, reveals a novel fold.

Authors:  Nina A Christ; Sophie Bochmann; Daniel Gottstein; Elke Duchardt-Ferner; Ute A Hellmich; Stefanie Düsterhus; Peter Kötter; Peter Güntert; Karl-Dieter Entian; Jens Wöhnert
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.